Peter
Analyst
Piper Sandler
Equibles does not estimate personal net worth.
About Peter
Peter is recorded as Analyst at Piper Sandler. Peter has spoken on 2 earnings calls across 2 companies, most recently for Rigel Pharmaceuticals Inc on November 5, 2026. Those appearances were for Rigel Pharmaceuticals Inc (RIGL) and Ardelyx, Inc. (ARDX). The companies whose calls Peter spoke on are classified in the Healthcare sector.
Peter on recent calls
“Just wondering on VEPANU, if you can comment on the sales split between academic and community oncologists thus far. And then when might you be in a position to provide more specific revenue guidance?”
“I'm just wondering how investors should frame the range of outcomes across the Phase III Excel doses, and what would you view as a clinically meaningful result?”
Affiliation history
-
Piper Sandler
Analyst
Transcript header (unverified)
Current
Company network
Ardelyx, Inc.
ARDX
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-11-03
View calls and events